Citigroup Inc Io Biotech, Inc. Transaction History

Citigroup Inc

  • $217 Billion
  • Q3 2025

A detailed history of Citigroup Inc transactions in Io Biotech, Inc. stock. As of the latest transaction made, Citigroup Inc holds 1,292 shares of IOBT stock, worth $1,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,292
Previous 314 311.46%
Holding current value
$1,111
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
BUY
$0.36 - $2.4 $352 - $2,347
978 Added 311.46%
1,292 $0
Q2 2025

Aug 11, 2025
BUY
$0.83 - $1.62 $260 - $508
314 New
314 $0
Q4 2024

Feb 12, 2025
BUY
$0.68 - $1.33 $3 - $6
5 New
5 $0
Q2 2022

Aug 10, 2022
BUY
$3.79 - $8.38 $3,168 - $7,005
836 Added 509.76%
1,000 $5,000
Q1 2022

May 12, 2022
BUY
$3.73 - $8.74 $611 - $1,433
164 New
164 $1,000

About IO Biotech, Inc.

IOBT Quotes by TradingView
  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $24.8M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email